CEOs and senior executives from DCAT Member Companies highlighted their companies’ major news at the DCAT Member Company Announcement Forum at DCAT Week.

By Patricia Van Arnum, Editorial Director, DCAT, [email protected] 

CEO and senior executives from DCAT Member Companies highlighted their companies’ major news at the DCAT Member Company Announcement Forum at DCAT Week, the flagship event of the Drug, Chemical & Associated Technologies Association (DCAT) and the premier event for the global bio/pharmaceutical business ecosystem. Companies reported the latest in expansion plans across the bio/pharmaceutical value chain: from drug substances (small-molecules and biologics) to drug products (solid dosage and injectable product forms) and packaging. In all, 20 companies took to the podium to make their announcements. The program kicked off DCAT Week on Monday March 23, 2026. 

Details of each company’s announcement can be found below. 

• Vetter Outlines Major Expansion Plan for Commercial & Clinical Fill–Finish
• Thermo Fisher Scientific Unveils $1-Billion CDMO Investment Plan
• Dottikon Provides Update on Multi-Year, $1-Billion Small-Molecule API Expansions
• Lonza Outlines Strategic Plan, Investments as Pure-Play CDMO
• Siegfried Expanding Small-Molecule Drug-Substance Capacity Through Key Acquisitions
• Samsung Biologics Adds US Biomanufacturing Capacity; Plans Expansion of Capacity for New Modalities; Partners with Lilly for Open Innovation Center
• Made Scientific Expanding Cell-Therapy Mfg at New Jersey HQ Site
• Hovione Investing $100 M in US Expansion, Advancing Global Manufacturing Network
• FUJIFILM Biotechnologies Provides Update on Multi-Year $8-Bn Expansion Plan
• Cambrex Expanding Small-Molecule API Capacity in US; Upgrading European Site
• Start-up Allos AI Announces Seed Funding for AI-Enabled Pharma R&D, Formulation Development
• HAS Healthcare Advanced Synthesis Group Announces $120-M Expansion Plan; Integration of Cerbios-Pharma
• BSP Pharmaceuticals Outlines $800-M-Plus Expansion Plan
• Boston Institute of Biotechnology Announces Biomanufacturing Expansions
• Axplora Expanding to Support HPAPI Production
• Grand River Aseptic Manufacturing Expanding Sterile Injectables Mfg Capacity
• Wilmington PharmaTech Expanding Small-Molecule API Mfg
• West Pharmaceutical Services Highlights Key Capital Projects in Contract Mfg Business
• Agno Pharma Expanding Small-Molecule API and Drug-Product Mfg
• Terumo Investing $500 M To Expand CDMO & Drug-Delivery Capabilities